Phase 0/I/II Cancer Prevention Clinical Trials Program Clinical Trials

Titlesort descending Intervention NCT ID Sponsor Status
Curcumin in Preventing Gastric Cancer in Patients With Chronic Atrophic Gastritis or Gastric... Curcumin, Laboratory Biomarker Analysis, Placebo, Quality-of-Life Assessment NCT02782949 National Cancer Institute (NCI) Recruiting
Defined Green Tea Catechin Extract in Preventing Liver Cancer in Patients With Cirrhosis Defined Green Tea Catechin Extract, Laboratory Biomarker Analysis, Pharmacological Study, Questionnaire Administration NCT03278925 National Cancer Institute (NCI) Recruiting
DNA Vaccine Therapy in Treating Patients With Chronic Hepatitis C Virus Infection DNA Plasmid Encoding Interleukin-12 INO-9012, Electroporation-Mediated Plasmid DNA Vaccine Therapy, HCV DNA Vaccine INO-8000, Laboratory Biomarker Analysis, Quality-of-Life Assessment NCT02772003 National Cancer Institute (NCI) Recruiting
Dolcanatide in Preventing Colorectal Cancer in Healthy Volunteers Laboratory Biomarker Analysis, Placebo, Questionnaire Administration, Dolcanatide NCT03300570 National Cancer Institute (NCI) Active, not recruiting
Erlotinib Hydrochloride in Preventing Liver Cancer in Patients With Cirrhosis of the Liver Erlotinib Hydrochloride, Laboratory Biomarker Analysis, Quality-of-Life Assessment NCT02273362 National Cancer Institute (NCI) Recruiting
Erlotinib Hydrochloride in Reducing Duodenal Polyp Burden in Patients With Familial Adenomatous... Erlotinib Hydrochloride, Laboratory Biomarker Analysis NCT02961374 National Cancer Institute (NCI) Recruiting
Exemestane in Treating Patients With Complex Atypical Hyperplasia of the Endometrium/Endometrial... Exemestane, Laboratory Biomarker Analysis, Pharmacological Study, Questionnaire Administration NCT03300557 National Cancer Institute (NCI) Recruiting
Iloprost in Preventing Lung Cancer in Former Smokers Iloprost, Laboratory Biomarker Analysis, Placebo, Quality-of-Life Assessment, Questionnaire Administration NCT02237183 National Cancer Institute (NCI) Recruiting
Metformin Hydrochloride in Preventing Oral Cancer in Patients With an Oral Premalignant Lesion Laboratory Biomarker Analysis, Metformin Hydrochloride NCT02581137 National Cancer Institute (NCI) Active, not recruiting
MUC1 Vaccine in Preventing Lung Cancer in Current and Former Smokers at High Risk for Lung Cancer MUC1 Peptide-Poly-ICLC Vaccine, Laboratory Biomarker Analysis NCT03300817 National Cancer Institute (NCI) Recruiting

Pages